Farquhar John C.M. sold $639K of HTFL
Farquhar John C.M. (Chief Executive Officer) sold 22,562 shares of Heartflow, Inc. (HTFL) at $28.31 ($0.64M total) on 2026-08-10 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest fact is the disclosed sale size, price, and post-transaction share count, which can influence short-term sentiment but does not change fundamentals by itself.
Market read
Insider selling under a 10b5-1 plan is typically a low-signal event; any trading impact is likely modest and short-lived.
What to watch
Traders may over-weight insider sales; without accompanying guidance, trial, or contract updates, the signal is usually weak.
Background
The article is an SEC Form 4 insider transaction disclosure for Heartflow, Inc. (HTFL).
Ticker impact
Heartflow CEO Farquhar John C.M. sold 22,562 shares at $28.31 under a 10b5-1 plan, reducing direct holdings to 436,280.
Likely limited, with any reaction more sentiment-driven than fundamentals-driven.
Form 4 shows a pre-arranged 10b5-1 open-market sale; the filing provides timing and size, but no new company-specific operational or financial information.
Market effects
Minimal; insider sale in a single healthcare/medical device name does not reset sector expectations.
None indicated.
None indicated.
Counterpoint
Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect routine liquidity rather than bearish information.
Key entities
- issuerHeartflow, Inc.
Company whose CEO insider sale is disclosed on Form 4.
- insiderFarquhar John C.M.
CEO and director who sold 22,562 shares at $28.31 under a 10b5-1 plan.
